5-HYDROXYTRYPTAMINE RELEASE FROM PLATELETS BY DIFFERENT RED WINES - IMPLICATIONS FOR MIGRAINE

被引:21
|
作者
PATTICHIS, K
LOUCA, LL
JARMAN, J
SANDLER, M
GLOVER, V
机构
[1] Department of Chemical Pathology, Queen Charlotte's and Chelsea Hospital, London, W6 0XG, Goldhawk Road
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION | 1995年 / 292卷 / 02期
关键词
5-HT; (5-HYDROXYTRYPTAMINE; SEROTONIN); RED WINE; PLATELET; MIGRAINE; HEADACHE;
D O I
10.1016/0926-6917(95)90010-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have confirmed our earlier finding that most red wines are able to bring about 5-hydroxytryptamine (5-HT, serotonin) release from platelets in vitro. Platelets from individual subjects manifested varying degrees of releasing ability but responded to different wines with a similar rank ordering. There was a high correlation (r = 0.87) between the effect of red wine and that of reserpine in different individuals. Some types of red wine caused a consistently higher release of 5-HT than others in all subjects; one red wine in particular resulted in negligible release. When several brands of this 'low-releasing' red wine were further examined, they all showed a lower activity than all the brands of a 'high-releasing' red wine type. This variation in releasing power was not related to intensity of red colour. Partial purification of red wine was achieved by column chromatography and showed releasing activity to be associated with a low molecular weight orange fraction. Preliminary studies, using solid phase extraction methods, showed that the active components lie mainly in a subgroup of the flavonoid fraction. If any of the adverse effects of red wine, such as headache induction, derive from this 5-HT releasing ability, then it may be possible to prepare red wines free from the chemical substances responsible.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 50 条
  • [31] 5-hydroxytryptamine in migraine: The puzzling role of ionotropic 5-HT3 receptor in the context of established therapeutic effect of metabotropic 5-HT1 subtypes
    Giniatullin, Rashid
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (03) : 400 - 415
  • [32] Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro
    H. Schwörer
    Giuliano Ramadori
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1998, 357 : 548 - 552
  • [33] OPIOID EFFECTS ON SPINAL [H-3] 5-HYDROXYTRYPTAMINE RELEASE ARE NOT RELATED TO THEIR ANTINOCICEPTIVE ACTION
    MONROE, PJ
    KRADEL, BK
    SMITH, DL
    SMITH, DJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 272 (01) : 51 - 56
  • [34] Adenosine A(3) receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine
    Sawynok, J
    Zarrindast, MR
    Reid, AR
    Doak, GJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 333 (01) : 1 - 7
  • [35] 5-HYDROXYTRYPTAMINE KINETICS AND ACTIVATION OF BLOOD-PLATELETS IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    FETKOVSKA, N
    AMSTEIN, R
    FERRACIN, F
    REGENASS, M
    BUHLER, FR
    PLETSCHER, A
    HYPERTENSION, 1990, 15 (03) : 267 - 273
  • [36] The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid
    Kirby, LG
    ChouGreen, JM
    Davis, K
    Lucki, I
    BRAIN RESEARCH, 1997, 760 (1-2) : 218 - 230
  • [37] EFFECT OF PHYSICAL STRESS ON 5-HYDROXYTRYPTAMINE UPTAKE KINETICS (KM AND VMAX) IN HUMAN PLATELETS
    ROLF, LH
    LANGE, U
    GROTEMEYER, KH
    BENNEFELD, H
    THROMBOSIS RESEARCH, 1992, 66 (2-3) : 159 - 167
  • [38] Magnolol decreases body temperature by reducing 5-hydroxytryptamine release in the rat hypothalamus
    Hsieh, MT
    Chueh, FY
    Lin, MT
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (10) : 813 - 817
  • [39] Anxiety but not arousal increases 5-hydroxytryptamine release in the rat ventral hippocampus in vivo
    Rex, A
    Voigt, JP
    Fink, H
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (05) : 1185 - 1189
  • [40] 5-HYDROXYTRYPTAMINE RELEASE IN DORSAL HIPPOCAMPUS OF FREELY MOVING RATS - MODULATION BY PINDOLOL
    BOSKER, FJ
    DONKER, MG
    KLOMPMAKERS, AA
    KURATA, K
    WESTENBERG, HGM
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (04): : 765 - 778